Development of a thermostable SARS-CoV-2 variant-based bivalent protein vaccine with cross-neutralizing potency against Omicron subvariants-Reference-Cited by-同舟云学术

Development of a thermostable SARS-CoV-2 variant-based bivalent protein vaccine with cross-neutralizing potency against Omicron subvariants

Published:2022-11 Issue: Volume:576 Page:61-68
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Wang Rui,Huang Xun,Cao Tianshu,Sun Chunyun,Luo Dan,Qiu Hongying,Wu Mei,Huang Xingyao,Yu Chulin,Li Jing,Kong Desheng,Ma Juan,Zhang Xiao,Hu Ping,Zhang Yanjing,Luo Chunxia,Zhao Hui,Li Yuchang,Deng Yongqiang,Qin Chengfeng,Xie Liangzhi

Publisher

Elsevier BV

Subject

Virology

Reference47 articles.

1. International risk of SARS-CoV-2 Omicron variant importations originating in South Africa;Bai;medRixv,2021

2. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting;Barda;N. Engl. J. Med.,2021

3. mRNA vaccines: a matter of delivery;Cao;EClinicalMedicine,2021

4. BA. 2.12. 1, BA. 4 and BA. 5 escape antibodies elicited by Omicron infection;Cao;bioRxiv,2022

5. Safety, immunogenicity and antibody persistence of a bivalent beta-containing booster vaccine;Chalkias;Res. Square,2022

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A superior heterologous prime‐boost vaccination strategy against COVID‐19: A bivalent vaccine based on yeast‐derived RBD proteins followed by a heterologous vaccine;Journal of Medical Virology;2024-03

2. Safety and immunogenicity of multivalent SARS-CoV-2 protein vaccines: a randomized phase 3 trial;eClinicalMedicine;2023-10

3. Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men;Nature Communications;2023-07-08

4. Regulation of Ethanol Assimilation for Efficient Accumulation of Squalene in Saccharomyces cerevisiae;Journal of Agricultural and Food Chemistry;2023-04-13

5. Safety and immunogenicity of a bivalent SARS-CoV-2 recombinant protein vaccine, SCTV01C in unvaccinated adults: A randomized, double-blinded, placebo-controlled, phase I clinical trial;Journal of Infection;2023-02